Basic Information
RNALocate ID: RLID:11002590
RNA Symbol: hsa-miR-342-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-342-3p
RNA ID: miRBase:MIMAT0000753
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23663360
Tissue/Cell Line: Plasma
Method: Next-generation RNA sequencing
Description: Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002053 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002054 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002055 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002056 Nucleolus HeLa cells 23940654
RLID:01002057 Nucleolus Breast adenocarcinoma cells (MCF-7) 24918059
RLID:01002058 Nucleus Neural progenitor cells 21363885
RLID:11002584 Exosome Serum 18589210
RLID:11002585 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002586 Exosome Breast cancer cell line (MCF-7) 20976003
RLID:11002587 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002588 Exosome Renal cancer cells 21670082
RLID:11002589 Exosome Brain tissue 23382797
RLID:11002591 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002592 Exosome Serum 25349172
RLID:11002593 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002594 Microvesicle Seminal plasma 23539611
RLID:11002595 Microvesicle Follicular fluid 23666971
RLID-D:11000129 Exosome B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Mast cells|Seminal fluid
RLID-D:11000430 Microvesicle Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-342-3p Diffuse large b cell lymphoma MNDR-E-MI-42082
MNDR hsa-miR-342-3p Splenic marginal zone lymphoma MNDR-E-MI-42083
MNDR hsa-miR-342-3p Multiple sclerosis chronic progressive MNDR-E-MI-42084
MNDR hsa-miR-342-3p Oral squamous cell carcinoma MNDR-E-MI-42085
MNDR hsa-miR-342-3p B cell lymphoma of malt type MNDR-E-MI-42086
MNDR hsa-miR-342-3p Lymphoma MNDR-E-MI-42087
MNDR hsa-miR-342-3p Lymphoma non-hodgkin MNDR-E-MI-42088
MNDR hsa-miR-342-3p Cutaneous t cell lymphoma MNDR-E-MI-42089
MNDR hsa-miR-342-3p Estrogen-receptor positive breast cancer MNDR-E-MI-42090
MNDR hsa-miR-342-3p Progesterone-receptor positive breast cancer MNDR-E-MI-42091
MNDR hsa-miR-342-3p Progesterone-receptor negative breast cancer MNDR-E-MI-42092
MNDR hsa-miR-342-3p Acute promyelocytic leukemia MNDR-E-MI-42093
MNDR hsa-miR-342-3p Breast cancer luminal MNDR-E-MI-42094
MNDR hsa-miR-342-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-42095
MNDR hsa-miR-342-3p B cell acute lymphoblastic leukemia MNDR-E-MI-42096
MNDR hsa-miR-342-3p Prostate cancer MNDR-E-MI-42097
MNDR hsa-miR-342-3p Gastric cancer MNDR-E-MI-42098
MNDR hsa-miR-342-3p Gastric lymphoma MNDR-E-MI-42099
MNDR hsa-miR-342-3p Alzheimer disease MNDR-E-MI-42100
MNDR hsa-miR-342-3p Intracranial aneurysm MNDR-E-MI-42101
MNDR hsa-miR-342-3p Dysautonomia familial MNDR-E-MI-42102
MNDR hsa-miR-342-3p Head and neck cancer MNDR-E-MI-42103
MNDR hsa-miR-342-3p Leukemia MNDR-E-MI-42104
MNDR hsa-miR-342-3p Huntington disease MNDR-E-MI-42105
MNDR hsa-miR-342-3p Chorea MNDR-E-MI-42106
MNDR hsa-miR-342-3p Cardiovascular disease MNDR-E-MI-42107
MNDR hsa-miR-342-3p Neurodegenerative diseases MNDR-E-MI-42108
MNDR hsa-miR-342-3p Lung cancer MNDR-E-MI-42109
MNDR hsa-miR-342-3p Parkinson disease MNDR-E-MI-42110
MNDR hsa-miR-342-3p Machado-joseph disease MNDR-E-MI-42111
MNDR hsa-miR-342-3p Breast cancer MNDR-E-MI-42112
MNDR hsa-miR-342-3p Pancreatic cancer MNDR-E-MI-42113
MNDR hsa-miR-342-3p Rectum adenocarcinoma MNDR-E-MI-42114
MNDR hsa-miR-342-3p Nephroblastoma MNDR-E-MI-42115
MNDR hsa-miR-342-3p Colon cancer MNDR-E-MI-42116
MNDR hsa-miR-342-3p Colon adenocarcinoma MNDR-E-MI-42117
MNDR hsa-miR-342-3p Relapsing-remitting multiple sclerosis MNDR-E-MI-42118
MNDR hsa-miR-342-3p Familial ovarian cancer MNDR-E-MI-42119
MNDR hsa-miR-342-3p Prostate adenocarcinoma MNDR-E-MI-42120
MNDR hsa-miR-342-3p Kidney cancer MNDR-E-MI-42121
MNDR hsa-miR-342-3p Carcinoma ductal breast MNDR-E-MI-42122
MNDR hsa-miR-342-3p Glioblastoma MNDR-E-MI-42123
MNDR hsa-miR-342-3p Glioma MNDR-E-MI-42124
MNDR hsa-miR-342-3p Chordoma MNDR-E-MI-42125
MNDR hsa-miR-342-3p Amyotrophic lateral sclerosis MNDR-E-MI-42126
MNDR hsa-miR-342-3p Osteosarcoma MNDR-E-MI-42127
MNDR hsa-miR-342-3p Breast carcinoma MNDR-E-MI-42128
MNDR hsa-miR-342-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-42129
MNDR hsa-miR-342-3p Meningioma MNDR-E-MI-42130
MNDR hsa-miR-342-3p Liver cancer MNDR-E-MI-42131
MNDR hsa-miR-342-3p Gastric adenocarcinoma MNDR-E-MI-42132
MNDR hsa-miR-342-3p Lung squamous cell carcinoma MNDR-E-MI-42133
MNDR hsa-miR-342-3p Carcinoma lung non-small-cell MNDR-E-MI-42134
MNDR hsa-miR-342-3p Lung adenocarcinoma MNDR-E-MI-42135
MNDR hsa-miR-342-3p Thyroid carcinoma MNDR-E-MI-42136
MNDR hsa-miR-342-3p Cervical cancer MNDR-E-MI-42137
MNDR hsa-miR-342-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-42138
MNDR hsa-miR-342-3p Carcinoma renal cell MNDR-E-MI-42139
MNDR hsa-miR-342-3p Kidney renal papillary cell carcinoma MNDR-E-MI-42140
MNDR hsa-miR-342-3p Clear cell renal cell carcinoma MNDR-E-MI-42141
MNDR hsa-miR-342-3p Cholangiocarcinoma MNDR-E-MI-42142
MNDR hsa-miR-342-3p Lung small cell carcinoma MNDR-E-MI-42143
MNDR hsa-miR-342-3p Variant creutzfeldt-jakob disease MNDR-E-MI-42144
MNDR hsa-miR-342-3p Head and neck squamous cell carcinoma MNDR-E-MI-42145
MNDR hsa-miR-342-3p T acute lymphoblastic leukemia MNDR-E-MI-42146
MNDR hsa-miR-342-3p Acute t cell leukemia MNDR-E-MI-42147
MNDR hsa-miR-342-3p Prion disease MNDR-E-MI-42148
MNDR hsa-miR-342-3p Breast invasive carcinoma MNDR-E-MI-42149
MNDR hsa-miR-342-3p Hepatocellular carcinoma MNDR-E-MI-42150
MNDR hsa-miR-342-3p Familiar ovarian carcinoma MNDR-E-MI-42151
MNDR hsa-miR-342-3p B-cell lymphoma MNDR-E-MI-42152
MNDR hsa-miR-342-3p Rheumatoid arthritis MNDR-E-MI-42153
MNDR hsa-miR-342-3p T-cell leukemia MNDR-E-MI-42154
MNDR hsa-miR-342-3p Malignant pleural mesothelioma MNDR-E-MI-42155
MNDR hsa-miR-342-3p Retinoblastoma MNDR-E-MI-42156
MNDR hsa-miR-342-3p Neuroblastoma MNDR-E-MI-42157
MNDR hsa-miR-342-3p Hodgkin lymphoma MNDR-E-MI-42158
MNDR hsa-miR-342-3p Burkitt lymphoma MNDR-E-MI-42159
MNDR hsa-miR-342-3p Tonsil cancer MNDR-E-MI-42160
MNDR hsa-miR-342-3p Neuromyelitis optica MNDR-E-MI-42161
MNDR hsa-miR-342-3p Skin cutaneous melanoma MNDR-E-MI-42162
MNDR hsa-miR-342-3p Skin melanoma MNDR-E-MI-42163
MNDR hsa-miR-342-3p Colorectal cancer MNDR-E-MI-42164
MNDR hsa-miR-342-3p Nasopharynx carcinoma MNDR-E-MI-42165
MNDR hsa-miR-342-3p Multiple myeloma MNDR-E-MI-42166
MNDR hsa-miR-342-3p Uterine cervical neoplasms MNDR-E-MI-42167
MNDR hsa-miR-342-3p Nasopharyngeal cancer MNDR-E-MI-42168
MNDR hsa-miR-342-3p Prostatic neoplasms MNDR-E-MI-42169
MNDR hsa-miR-342-3p Sleep deprivation MNDR-E-MI-42170
MNDR hsa-miR-342-3p Epstein-barr virus infections MNDR-E-MI-42171
MNDR hsa-miR-342-3p Subarachnoid hemorrhage traumatic MNDR-E-MI-42172
MNDR hsa-miR-342-3p Intracranial hemorrhage hypertensive MNDR-E-MI-42173
MNDR hsa-miR-342-3p Stroke lacunar MNDR-E-MI-42174
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ANKRD49 Homo sapiens RR00081534
TOP